{
    "title": "Atrial-Selective Potassium Channel Blockers.",
    "doc_id": "27261831",
    "writer": "Voigt N",
    "year": "2016",
    "summary": "Atrial fibrillation (AF) is associated with increased morbidity and mortality. Atrial-selective potassium (K(+)) channel blockers may represent a novel therapeutic target. ...Two-pore domain and small-conductance Ca(2+)-activated K(+) channels and Kv1.1 channels may â€¦",
    "abstract": "Atrial fibrillation (AF) is associated with increased morbidity and mortality. Atrial-selective potassium (K(+)) channel blockers may represent a novel therapeutic target. The best validated atrial-specific ion currents are the acetylcholine-activated inward-rectifier K(+) current IK,ACh and ultrarapidly activating delayed-rectifier K(+) current IKur. Two-pore domain and small-conductance Ca(2+)-activated K(+) channels and Kv1.1 channels may also contribute to the atrial repolarization. We review the molecular and electrophysiologic characteristics of atrial-selective K(+) channels and their potential pathophysiologic role in AF. We summarize currently available K(+) channel blockers focusing on the most important compounds.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/27261831/"
}